Shilpa Keerthivasan to Immunotherapy
This is a "connection" page, showing publications Shilpa Keerthivasan has written about Immunotherapy.
Connection Strength
0.075
-
CD8+ TÂ cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy. Cell Rep Med. 2023 01 17; 4(1):100878.
Score: 0.038
-
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors. Cancer Discov. 2022 11 02; 12(11):2606-2625.
Score: 0.037